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Chest pain in patients presenting to the emergency department (ED) has a plethora of etiologies 
and electrocardiographic (ECG) manifestations. Admission to the hospital from the ED with chest 
pain will likely place the patient on a telemetry monitored unit for continued cardiac monitoring, 
specifically monitoring the ST-segment that can detect ischemia. The current guideline for in-
hospital cardiac monitoring lists a few exclusions to ST-segment ischemia monitoring such as 
bundle-branch blocks, ventricular rhythms, and coarse atrial fibrillation or flutter (Drew et al., 
2004). These conditions alter the ST-segment for reasons unrelated to acute myocardial ischemia, 
triggering ST-segment monitor alarms that can lead to alarm fatigue, misdiagnosis, or 
inappropriate treatment. The purpose of this study is to determine the prevalence and clinical 
significance of these non-ischemic ECG abnormalities that alter the ST-segment and affect the 
healthcare professionals’ accurate assessment of myocardial ischemia in patients that present to 
the ED with a chief complaint of chest pain. This study includes a secondary analysis of the 
ongoing Electrocardiographic Methods for Prompt Identification of Coronary Events (EMPIRE) 
study data set, which aims to quantify ischemia-induced repolarization dispersion for early non-
ST elevation myocardial infarction detection. The parent study has created a database of patients 
who arrive via ambulance to the ED with a chief complaint of chest pain (Al-Zaiti, Martin-Gill, 
Sejdic, Alrawashdeh, & Callaway, 2015). In this secondary analysis, the demographic, clinical, 
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and ECG data from 750 consecutively enrolled patients were assessed for acute coronary syndrome 
risk factors and ECG abnormalities, including secondary repolarization changes that interfere with 
ST-segment monitoring. 75% of patients were admitted and 16% of patients overall had 
confounders for ST-segment monitoring. Significant relationships between ST-segment 
monitoring confounders and important clinical variables such as age, coronary artery disease risk 
factors, and length of stay were found. Determination of the prevalence of ECG abnormalities that 
affect the ST-segment would provide valuable information on the clinical utility of ST-segment 
monitoring in chest-pain populations. 
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1.0  INTRODUCTION 
Chest pain is the second leading cause of emergency department visits in the United States; 
approximately six million Americans annually visit emergency departments with a chief complaint 
of chest pain (Hollander & Chase, 2016). Etiologies of chest pain may be life-threatening if 
involving the heart or lungs, such as acute coronary syndrome (ACS), pulmonary embolism, 
cardiac tamponade, and tension pneumothorax. Other non-cardiac causes that may cause chest 
pain are pneumonia, acid reflux, and musculoskeletal pain (Hollander & Chase, 2016). Ruling out 
life-threatening conditions, such as ACS or pulmonary embolism, is the priority during the 
evaluation of chest pain at the ED. ACS results from a ruptured plaque or thrombus that obstructs 
blood flow in a coronary artery and thus starves the cardiac tissue of oxygen, called myocardial 
ischemia, possibly leading to cell injury and death, called myocardial infarction. While the 
population presenting to the ED with chest pain is heterogeneous, the initial ED evaluation of these 
patients is consistent: history and physical examination, a 12-lead ECG, and evaluation of serum 
cardiac biomarkers of myocardial infarction, such as troponin level (Hollander & Chase, 2016). 
The 12-lead ECG is the principle tool for evaluating chest-pain patients, regardless of 
etiology and risk factor assessment. The ST-segment portion of the electrocardiogram is normally 
isoelectric, so ST elevation or depression is clinically indicative of myocardial ischemia or 
infarction (Prutkin, 2016). A chest-pain patient with an ECG showing ST-segment elevation can 
be immediately diagnosed with an ST elevation myocardial infarction (STEMI) and would 
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immediately be sent for percutaneous coronary intervention (PCI) for revascularization. If the 
patient’s ECG shows either ST-segment depression or minimal ST-segment deviation, it is 
inconclusive. In that case, cardiac biomarkers, such as troponins, are tested for with a simple blood 
draw lab test. Positive troponins in these patients would then indicate a non-ST elevation 
myocardial infarction (NSTEMI) and anticoagulation or PCI should be considered (Hollander & 
Chase, 2016). Unfortunately, troponin may take up to 24 hours to rise and reach a peak level and, 
in some patients, might remain negative despite critical coronary artery disease, such as in unstable 
angina (Troponin test, 2015). Therefore, the presence or absence of ACS (i.e., STEMI, NSTEMI, 
or unstable angina) frequently cannot be determined at the ED and might require admission for 
advanced diagnostics, such as nuclear perfusion imaging, and for telemetry monitoring to detect 
transient and evolving ECG changes. 
Chest-pain patients who have negative initial assessments for ACS but also have risk 
factors such as a high body mass index (BMI), coronary artery disease history, tobacco use, and 
an age over 55, will likely be admitted to a telemetry unit for further evaluation and monitoring 
(Hollander & Chase, 2016). While on a telemetry unit, these undiagnosed chest-pain patients will 
likely be placed on ST-segment monitoring to detect ST amplitude changes that trigger an alarm. 
The American Heart Association (AHA) published a guideline for in-hospital telemetry 
monitoring in 2004 to establish practice standards for ST-segment monitoring (Drew et al., 2004). 
Although these recommendations are widely adopted in clinical practice, there are still 
unmet needs in clinical settings. Specifically, there are some ECG confounders that preclude 
proper interpretation of the 12-lead ECG but are generally unrelated to the underlying cause of the 
chest pain (Rautaharju et al., 2009). These ECG confounders lead to secondary changes in the ST-
T waveform that are not related to ischemia.  For instance, while a chest-pain patient might present 
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with pneumonia, his or her ECG might show a bundle branch block. The latter is not caused by 
the pneumonia, but would lead to secondary ST-T changes, which would impede the assessment 
of myocardial ischemia in this patient. Identified ECG confounders include left bundle-branch 
block (LBBB), frequent intermittent right bundle-branch block (RBBB), ventricular pacing 
rhythm, coarse atrial fibrillation or flutter, and intermittent accelerated ventricular rhythm (Drew 
et al., 2004). Left ventricular hypertrophy (LVH) with strain pattern is also known to set off false 
ST-segment alarms (Rautaharju et al., 2009; Drew, Wung, Adams, & Pelter, 1998). Essentially, 
the computer ST measurement for these identified ECG abnormalities would indicate ST deviation 
for reasons other than ischemia.  
Although these patients with ST confounders are potentially high risk patients with 
cardiopulmonary compromise, current guidelines recommend against using ST-segment 
monitoring when these ECG confounders exist. They are not excluded because they are at minimal 
risk for ischemia, but rather because computer measurement of ST amplitude cannot be trusted. 
Unfortunately, there are no alternative methods available for monitoring ischemia in these patients. 
Nurses are the primary observers of these patients, but they lack proper training in ST-segment 
monitoring and the understanding of ST confounders. Consequently, nurses frequently turn off 
ST-segment monitoring alarms in these patients, limiting the value of telemetry monitoring for 
which these patients were admitted in the first place. 
An example scenario is an overweight, older adult male who has smoked for 30 years and 
has hypertension who comes to the hospital with chest pain. His initial troponin may be negative 
and his presenting ECG may show what looks like a STEMI, but it is evaluated further and is a 
previously-documented LBBB. This patient is at high risk not only for ACS but also for heart 
failure related to left ventricular dyssynchrony (Sauer, 2014.) This patient will likely be admitted 
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and placed on telemetry monitoring, but will constantly trigger the ST-segment alarm, thus 
deeming the feature not useful. The patient should still be monitored, but if not with ST-segment 
monitoring, then how? 
The question then becomes: what is the frequency of chest-pain patients with secondary 
repolarization changes that induce non-ischemic ST changes, making them ineligible for ST-
segment monitoring?  It is important to identify patients that are at high risk for ACS and 
cardiopulmonary instability, such as patients with LBBB. Additionally, these high-risk patients 
may experience longer hospital stays because reaching a conclusive diagnosis may be hindered by 
confounding ECG abnormalities. Evidence suggests that healthcare professionals should not only 
be relying on telemetry monitoring for observation, but should also implement other measures to 
closely observe these patients. Quantifying the magnitude of this problem would be the first step 
to inform future development of targeted interventions. The primary purpose of this thesis is to 
define the prevalence and clinical significance of these non-ischemic ST-T changes in patients 
presenting to the ED with a chief complaint of chest pain. 
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2.0  BACKGROUND 
The electrocardiogram illustrates the electrical activity of the cardiac conduction system. A normal 
ECG waveform (Figure 1A) starts with the P wave as the first positive deflection representing 
depolarization of the atria, followed by the QRS complex, which signifies ventricular 
depolarization. The T wave denotes the repolarization of the ventricles, and the isoelectric ST-
segment shows an electrocardiographic resting period between ventricular depolarization and 
repolarization (Prutkin, 2016). Figure 1B illustrates ST elevation that is specific to acute 
myocardial ischemic injury, while figure 1C illustrates ST depression that may be seen during 
myocardial ischemia in some patients but may in fact be indicative of other pathologies. Figure 
1D illustrates another manifestation of ST elevation that is caused by secondary repolarization 
changes, which preclude proper interpretation of ST-segment and render ST-segment monitoring 
useless. 
 
 
Figure 1. Normal and Abnormal Electrocardiographic Waveform Patterns 
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In 2004, the American Heart Association published the currently used practice standards 
for ECG monitoring in-hospital settings. In this guideline, best practices are presented based on 
expert opinion on what types of patients should be monitored and what monitoring settings should 
be applied (Drew et al., 2004). Specifically, ST-segment ischemia monitoring is addressed and 
categorizes patients into classes of clinical situations in which some patients should have ST-
monitoring and others do not need it. ST-monitoring is utilized because ST-segment amplitude 
changes, such as elevation or depression, usually indicate myocardial ischemia or infarct. Class III 
is defined as the category of patients who are so low of a risk that no therapeutic benefits are gained 
from cardiac monitoring. Class III for ST-monitoring includes patients with left bundle-branch 
block (LBBB), frequent intermittent right bundle-branch block (RBBB), ventricular pacing 
rhythm, coarse atrial fibrillation or flutter, and intermittent accelerated ventricular rhythm (such as 
ventricular tachycardia) (Drew et al., 2004). However, within the context of chest pain, patients 
with these ECG abnormalities are in fact at the highest risk for dire outcomes (Anderson et al., 
2013). Thus, the recommendation of no ST-segment monitoring is based solely on the inability to 
accurately interpret ST-segment changes in patients with ECG confounders rather than on their 
low risk for an adverse outcome. 
According to AHA recommendations for interpretation of an ECG (Rautaharju et al., 
2009), secondary repolarization changes are defined as “abnormalities in the ST-segment and T 
wave that occur as a direct result of changes in the sequence and/or duration of ventricular 
depolarization, manifested electrocardiographically as changes in QRS shape and/or duration.” 
The previously described ECG abnormalities that alter ST-segment are considered examples of 
secondary repolarization changes.  
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Patients with these ECG abnormalities render ST-monitoring ineffective because they have 
secondary repolarization changes or unstable ST-amplitudes from “chaotic atrial activity”, 
unrelated to myocardial ischemia or infarction, that would cause an ST-monitor to be constantly 
alarming, leading to alarm fatigue in telemetry floor nurses (Drew et al., 2004). This raises the 
question of what decisions clinicians should make regarding a patient who has an ECG 
abnormality that renders ST-monitoring useless, such as LBBB, who is admitted for telemetry 
monitoring to rule out acute coronary syndrome. Healthcare providers would elect to admit 
patients at high risk for ACS for further observation, but how nurses should monitor and observe 
patients with ST-segment monitoring confounders remains open for discussion. 
A recent study found that almost 50 percent of patients who presented with chest pain over 
a five-year period to a hospital system were admitted (Weinstock et al., 2015). With healthcare 
costs rising, admitting every other patient of the 6 million Americans visiting ED for chest pain 
adds a tremendous burden on healthcare systems and aggravates nursing shortages, especially in 
acute care settings. To what extent secondary repolarization changes are prevalent in these 
admitted patients remains unclear, which complicates the problem of chest pain even further. The 
role of ST-segment monitoring in these patients is limited and only adds to the burden of alarm 
fatigue among critical care nurses. The first step to address this issue would be to quantify the 
magnitude of the problem; what is the prevalence of secondary repolarization changes in chest-
pain patients and how does this interfere with telemetry monitoring decisions? 
Based on an existing data set of ECGs collected on patients that were enrolled during 
hospital transport via ambulance for a chief complaint of chest pain, prevalence of ECG 
abnormalities that are defined in literature as having non-ischemic ST changes was investigated, 
specifically among admitted patients. This investigation on practice recommendations will provide 
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insight into the need for developing new approaches to observing chest-pain patients who are 
admitted for close observation for ischemia but who have an uninterpretable ECG for ST-segment 
changes. 
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3.0  PURPOSE 
The purpose of this secondary analysis is to define the frequency of chest-pain patients with ST 
confounders and evaluate the clinical significance of these ECG abnormalities. Using an existing 
data set collected via observational study of a cohort of consecutive chest-pain patients at the ED, 
this thesis will investigate the following specific aims: 
Specific Aim 1: Determine the magnitude of the problem among patients evaluated in the 
ED for chest pain: 
Aim 1(a). What is the distribution of ischemic vs. non-ischemic causes of chest pain? 
Aim 1(b). What percentage of patients admitted to a telemetry unit to rule out ACS had a 
final diagnosis of non-ischemic chest pain? 
Aim 1(c). What is the prevalence of ECG abnormalities that lead to secondary non-
ischemic ST changes or interfere with proper ST measurement? 
Specific Aim 2: Investigate the relationship between the presence of non-ischemic ST 
confounders and other important clinical variables: 
Aim 2(a).  Is there a relationship between the presence of non-ischemic ST confounders 
and demographic and clinical characteristics of patients? 
Aim 2(b). Is there a relationship between the presence of non-ischemic ST confounders 
and chest pain etiology? 
Aim 2(c). Is there a relationship between the presence of non-ischemic ST confounders 
and course of hospitalization? 
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4.0  METHODS 
4.1 DESIGN 
This thesis is a secondary dataset analysis of Electrocardiographic Methods for Prompt 
Identification of Coronary Events (EMPIRE) (Al-Zaiti, Martin-Gill, Sejdic, Alrawashdeh, & 
Callaway, 2015). EMPIRE is an ongoing, prospective, observational cohort study for building a 
database of chest-pain patients in Pittsburgh for expediting identification and treatment of 
NSTEMI. EMPIRE enrolled consecutive patients that called 9-1-1 for a chief complaint of chest 
pain and were transported via ambulance to one of three UPMC-affiliated hospitals in Pittsburgh, 
PA. Inclusion criteria were age 18 or older, chief complaint of non-traumatic chest pain or 
equivalent (e.g., shortness of breath, palpitation, etc.), arrival to the hospital via ambulance, and 
acquisition of a 12-lead ECG during prehospital transport. Exclusion criteria were traumatic chest-
pain patients and absence of pre-hospital ECG. 
The EMPIRE study was approved by the University of Pittsburgh IRB under a waiver of 
informed consent to facilitate the creation of a representative, unbiased cohort of consecutive chest 
pain cases. The current secondary analysis was approved by Dr. Salah Al-Zaiti. The parent study 
was minimal risk as it collected routine care data and there was no patient contact; data were 
extracted from electronic medical records by reviewers blinded to study outcomes. All extracted 
data were de-identified before storage and a linkage list was kept separate from the data; both 
measures were taken to reduce the risk of breach of confidentiality. 
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4.2 DEMOGRAPHIC AND CLINICAL DATA 
Relevant demographic and clinical data to be studied in this secondary analysis were 
identified. Given that age, sex, and race are well-known considerations in the interpretation of 
electrocardiographic data, they will be included as key demographic data in the current secondary 
analysis (Macfarlane, McLaughlin, Devine, & Yang, 1994). Other clinically-relevant variables that 
will be included as key clinical variables for the current investigation include obesity class, 
smoking history, and presence of the following diseases: hypertension, diabetes mellitus, 
hyperlipidemia, coronary artery disease (CAD), and angina. Past cardiac history of MI, congestive 
heart failure (CHF), or coronary artery bypass graft (CABG) or PCI will also be included in the 
analysis. Variables regarding clinical presentation (e.g., symptomatology, diagnostic tests, and 
course of hospitalization) will also be assessed. For example, ischemic changes on the presenting 
ECG will be evaluated using the Universal Definition criteria for the identification of MI 
(Thygesen et al., 2012).  
The demographic and clinical data described in this section will be used as independent 
variables in relation to study outcomes and predictors. Age will be defined as a continuous 
variable, and sex and race as dichotomous variables. Obesity class will be defined according to 
WHO as: normal weight is 18.5-24.9kg/m2, overweight is 25-29.9kg/m2, and obesity is over 30 
kg/m2 (BMI classification, 2017). Other key clinical variables (i.e., past medical history and 
clinical presentation) will be defined as dichotomous. Length of stay will be defined as the number 
of days and hours a patient is in the hospital (e.g. 1.6 days). 
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4.3 CLINICAL OUTCOMES 
Etiology of chest pain. Chest pain can be induced by multiple causes. In this thesis, etiology is 
defined as (1) ACS (i.e., STEMI, NSTEMI, or unstable angina), (2) non-ischemic 
cardiopulmonary (e.g., stable angina, pulmonary embolism, pneumonia, cardiac tamponade, 
tension pneumothorax, valvular heart disease, and heart failure), (3) other non-cardiac causes (e.g., 
gastrointestinal related, substance related, etc.), and (4) undifferentiated chest pain (e.g., 
musculoskeletal, unknown, etc.).  
Admission status. The course of hospitalization will be defined as if the patient was (1) discharged 
from the emergency department (length of stay <12 hours), (2) admitted to telemetry for overnight 
observation (length of stay ≤36 hours), or (3) admitted to the hospital for treatment of underlying 
pathology (length of stay ≥36 hours).  
ST-segment monitoring confounders.  These ECG confounders will be defined as either secondary 
ST changes induced by non-ischemic causes or causes that interfere with proper ST measurement. 
ST changes induced by non-ischemic causes include left bundle branch block (LBBB), left 
ventricular hypertrophy (LVH) with strain pattern, ventricular pacing, and ventricular rhythm. 
Causes that interfere with computerized ST measurement include coarse atrial fibrillation or flutter 
(AFib) and frequent intermittent right bundle branch block (RBBB). Each 12 lead ECG will be 
assessed for the presence of any of the listed abnormalities using the standardized criteria defined 
in Table 1.  
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Table 1. ECG Diagnostic Criteria Used for Interpretation 
 ECG Abnormality Description Coding 
Is
ch
em
ic
 C
ha
ng
es
 
ST Elevation 
New ST elevation at J point in 2 contiguous 
leads with cut-points: ≥0.1 mV in all leads other 
than V2-V3; ≥0.2 mV men less than 40, ≥0.25 
mV men over 40, ≥0.15 mV in women 
(Thygesen et al., 2012). 
Y/N 
ST Depression 
New horizontal or down-sloping ST depression 
≥0.05 mV in two contiguous leads (Thygesen et 
al., 2012). 
Y/N 
Se
co
nd
ar
y 
ST
 C
ha
ng
es
 In
du
ce
d 
by
 N
on
-
Is
ch
em
ic
 C
au
se
s 
Left Bundle Branch 
Block 
QRS area >1/4 of (QRS duration × maximum R 
amplitude) in lead I or V6, QRS >120 ms, QRS 
balance negative in lead V1 and V2 (Tan, 
Sungar, Myers, Sandri, & Froelicher, 2009). 
Y/N 
Left ventricular 
hypertrophy with 
strain 
S in V1 + R in V5 > 35 mm, with ST depression 
and T wave inversion (Hancock et al., 2009). Y/N 
Ventricular Pacing 
Prolonged QRS complexes with discordant T 
waves during the presence of ventricular 
pacemaker spikes (Zehender et al., 1992). 
Y/N 
Ventricular Rhythm 
Prolonged QRS complexes due to non-sinus 
activity below the AV node (e.g., ventricular 
tachycardia or third degree heart block) 
(Goldberger et al., 2008). 
Y/N 
C
au
se
s t
ha
t I
nt
er
fe
re
 w
ith
 
Pr
op
er
 S
T-
se
gm
en
t 
M
ea
su
re
m
en
t 
Coarse Atrial 
fibrillation/flutter 
R-R interval variability with lack of discernible P 
wave and visible atrial waveforms causing 
artifact; fluctuating ST amplitudes from chaotic 
atrial activity (Tan, Sungar, Myers, Sandri, & 
Froelicher, 2009; Drew et al., 2004) 
Y/N 
Right Bundle Branch 
Block 
QRS duration>120 ms, QRS area in lead 1 
positive, no terminal S wave in lead V1, S 
amplitude + ST junction <100 mV and <R 
amplitude in lead V1 (Tan, Sungar, Myers, 
Sandri, & Froelicher, 2009). 
Y/N 
 
 14 
4.4 DATA COLLECTION AND CODING 
ECG Data. The EMPIRE dataset obtained the presenting 12-lead ECG at the ED in a standard PDF 
format. All ECGs were de-identified and saved to a research drive protected by UPMC firewall. 
First, a reviewer (ED medical resident), blinded to clinical data, interpreted each 12-lead ECG 
using study definitions (Table 1) and logged his annotations in an excel sheet. Second, a 
manufacturer-specific automated algorithm interpreted the same ECG confounders and logged in 
its annotation on the same excel sheet. Finally, a third reviewer (research scientist) adjudicated 
any disagreement between the blinded reviewer and the automated algorithm.  
Clinical Outcomes. A reviewer blinded from all ECG analyses reviewed the entire hospital record 
of the indexed visit for each patient and determined the etiology of chest pain as either ACS, non-
ischemic cardiopulmonary disease, non-cardiac related disease, or undifferentiated cause as 
previously defined. The reviewer also classified the course of hospitalization as either patient 
discharged from ED, patient admitted for overnight observation/further testing, or patient admitted 
for treatment of serious underlying pathology. 
4.5 STATISTICAL ANALYSIS 
The data were analyzed using IBM’s SPSS 22 software and all variables were reviewed for normal 
distribution, and descriptive analyses were reported as mean ± standard deviation or median (inter-
quartile range) for continuous variables and n (%) for categorical variables. Age and length of stay 
were continuous, and all other key demographic and clinical variables are categorical as previously 
described. Clinical outcomes were also defined as categorical: etiology (4 mutually exclusive 
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groups); course of hospitalization (3 mutually exclusive groups); presence of non-ischemic ST 
confounders (yes/no). Comparisons between groups were done using independent samples t-test 
for continuous variables and chi-square for categorical variables. Length of stay was compared 
between groups using Mann-Whitney U test. Significance level was set as p < 0.05 two tailed for 
hypothesis testing. 
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5.0  RESULTS 
5.1 BASELINE CHARACTERISTICS 
As shown in table 2, the sample size was 750 patients with a mean age of 59±17 years old. 433 
(58%) of patients were males, and 301 (40%) of the patients were African Americans. The sample 
had 445 (59%) patients that were overweight or obese, and 436 (58%) of the patients were former 
or current smokers. Hypertension was the most prevalent disease (73%), then hyperlipidemia 
(35%), coronary artery disease (34%), and lastly diabetes mellitus (28%). 31% of the sample 
population had a history of a previous myocardial infarction, 23% had a past percutaneous 
coronary intervention and 9% had a previous coronary artery bypass graft. 18% had a history of 
congestive heart failure. 
Majority of the sample (86%) presented with chest pain, only 13% had an initial positive 
troponin, and majority of the patients (82%) had normal serum potassium levels. According to 
their initial ECGs, majority of the patients (86%) were initially in sinus rhythm, only 73 (10%) 
were in atrial fibrillation. 223 (30%) of the patients had T wave inversion, 153 (20%) had ST-
segment depression, and 55 (7%) had ST-segment elevation. Nearly 9% were treated by PCI, and 
1% underwent CABG. 
 
 
Table 2. Baseline Sample Characteristics 
n=750 
Demographics 
Age Mean 59±17 years (19-100) 
Sex (Male) 433 (58%) 
Race (Black) 301 (40%) 
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CAD Risk Factors 
Obesity class  
Normal 303(41%) 
Overweight 160 (21%) 
Obese 285 (38%)  
Smoking History  
Never 307 (41%) 
Quit 273 (37%)  
Current 163 (22%) 
Hypertension 547 (73%) 
Diabetes Mellitus 210 (28%) 
Hyperlipidemia 262 (35%) 
Coronary Artery Disease 
(CAD) 
256 (34%) 
Angina 146 (20%) 
History of MI 231 (31%) 
History of CHF 135 (18%) 
Past PCI 172 (23%) 
Past CABG 70 (9%) 
Clinical Presentation 
Chest Pain 645 (86%) 
Shortness of Breath 215 (29%) 
Positive Initial Troponin 96 (13%) 
Serum Potassium Level  
Hypokalemia 113 (15%) 
Normal 614 (82%) 
Hyperkalemia 23 (3%) 
Rhythm  
Sinus 646 (86%) 
Ventricular Rhythm 8 (1%) 
Atrial fibrillation/flutter 73 (10%) 
Pacing 23 (3%) 
Ischemic Changes  
ST-segment Elevation 55 (7%) 
ST-segment Depression 153 (20%) 
T Wave Inversion 223 (30%) 
Course of Hospitalization 
Admitted  
Discharged from ED 193 (26%) 
Admitted overnight 234 (31%) 
Admitted for treatment 323 (43%) 
Length of Stay (mean±SD) 2.3±3.6 days (0-51) 
Final Impression  
ACS 130 (17%) 
Non-ischemic cardiopulmonary 237 (32%) 
Non-cardiac 69 (9%) 
Undifferentiated CP 314 (42%) 
PCI Done 65 (9%) 
CABG Done 9 (1%) 
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5.2 SPECIFIC AIM 1(A) 
As shown in Figure 2, nearly 1 in 5 patients had an ischemic cause of chest pain. The most 
prevalent final diagnosis for chest pain was undifferentiated (42%), followed by non-ischemic 
cardiopulmonary (32%), ACS (17%), and non-cardiac related (9%). 
 
 
Figure 2. Chest Pain Etiologies 
5.3 SPECIFIC AIM 1(B) 
As shown in figure 3, more than one quarter of patients were discharged from the ED and nearly 
one third were admitted to telemetry for overnight observation. Of note, more than 50% of those 
admitted for observation had an undifferentiated etiology for chest pain. Among those admitted 
for treatment, majority were non-ischemic cardiopulmonary etiology followed by ACS patients. 
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Figure 3. Chest Pain Etiology and Outcomes 
5.4 SPECIFIC AIM 1(C) 
As shown in Table 3, (1) 80 patients (10.7%) had at least one cause that leads to secondary non-
ischemic ST changes, (2) 49 patients (6.5%) had a cause that interferes with proper ST 
measurement. Specifically, LVH with strain was the most common (3.6%) cause for secondary 
non-ischemic ST changed, followed by pacing and LBBB. The presence of intermittent RBBB 
(4.3%) was the most common cause that interferes with proper ST measurement, followed by 
coarse AFIB (2.4%). Overall, about 1 in 6 patients evaluated at ED for chest pain have confounders 
to ST-segment monitoring (Figure 4). 
 
Table 3. Prevalence of Non-Ischemic ST Confounders 
Causes that lead to Secondary Non-Ischemic ST Changes 
LBBB 22 (2.9%) 
LVH with strain 27 (3.6%) 
Pacing 23 (3.1%) 
Ventricular Rhythm 8 (1.1%) 
TOTAL 80 (10.7%) 
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Causes that Interfere with Proper ST Measurement 
Coarse AFIB 18 (2.4%) 
Intermittent RBBB 32 (4.3%) 
TOTAL 49 (6.5%) 
Any ST Confounder 123 (16.4%) 
 
 
Figure 4. Prevalence of Non-Ischemic ST Confounders 
5.5 SPECIFIC AIM 2(A) 
As shown in table 4, older age and the presence of hypertension, coronary artery disease, angina, 
history of CHF, and past CABG are univariately associated with the presence of ST confounders 
(p<0.001). ST confounders are also related to diabetes mellitus (p=0.001), hyperlipidemia 
(p=0.007), history of MI (p=0.018), and past PCI (p=0.002). Length of stay, as calculated by the 
Mann-Whitney U Test, was also related to presence of confounders (p= <0.001).    
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Table 4. Baseline Characteristics in relation to presence of ST Confounders 
Variables 
Confounder 
Present 
(n=123) 
Confounder 
Absent 
(n=627) 
P Value 
Demographics  
Age (years) Mean 59±17  68 ± 16 57 ± 16 <0.001 
Sex (Male) 433 (58%) 75 (61%) 358 (57%) 0.43 
Race (Black) 301 (40%) 50 (41%) 251 (40%) 0.69 
CAD Risk Factors 
Obesity class    0.37 
Normal 303(41%) 55 (45%) 248 (40%)  
Overweight 160 (21%) 28 (23%) 132 (21%)  
Obese 285 (38%)  40 (32%) 245 (39%)  
Smoking History    0.41 
Never 307 (41%) 56 (46%) 251 (40%)  
Quit 273 (37%)  44 (36%) 229 (37%)  
Current 163 (22%) 22 (18%) 141 (23%)  
Hypertension 547 (73%) 108 (88%) 439 (70%) <0.001 
Diabetes Mellitus 210 (28%) 49 (40%) 161 (26%) 0.001 
Hyperlipidemia 262 (35%) 56 (46%) 206 (33%) 0.007 
CAD 256 (34%) 71 (58%) 185 (30%) <0.001 
Angina 146 (20%) 40 (33%) 106 (17%) <0.001 
History of MI 231 (31%) 49 (40%) 182 (29%) 0.018 
History of CHF 135 (18%) 44 (36%) 91 (15%) <0.001 
Past PCI 172 (23%) 43 (36%) 129 (21%) 0.002 
Past CABG 70 (9%) 29 (24%) 41 (7%) <0.001 
Clinical Presentation  
Chest Pain 645 (86%) 105 (85%) 540 (86%) 0.83 
Shortness of Breath 215 (29%) 42 (34%) 173 (28%) 0.15 
Positive Initial 
Troponin 
96 (13%) 21 (17%) 75 (12%) 0.122 
Serum K+ Level    0.28 
Hypokalemia 113 (15%) 14 (12%) 99 (17%)  
Normal 614 (82%) 101 (84%) 451 (79%)  
Hyperkalemia 23 (3%) 5 (4%) 18 (3%)  
LOS (median [IQR]) 1.0 (0.5-3.0) 2.0 (1.0-3.0) 1.0 (0.2-3.0) <0.001 
PCI Done 65 (9%) 13 (11%) 52 (8%) 0.41 
CABG Done 9 (1%) 3 (2%) 6 (1%) 0.17 
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5.6 SPECIFIC AIM 2(B) 
As shown in figure 5, ST confounders are prevalent in all patients with chest pain irrespective to 
the etiology of chest pain. For example, 12% of patients with undifferentiated chest pain has at 
least 1 ST confounder; compared to 20% in those with ACS. Compared to patients with non-
cardiac or undifferentiated causes of chest pain, those with cardiac-related cause of chest pain 
(ACS or non-ischemic cardiopulmonary disease) were more likely to have ST confounders on their 
ECG (chi-square =18.9, p<0.001).  
 
Figure 5. Relationship between presence of ST Confounders and Chest Pain Etiology 
5.7 SPECIFIC AIM 2(C) 
Finally, as shown in figure 6, the presence of ST confounders was not only prevalent among 
patients admitted for treatment but also among those discharged from ED or admitted to telemetry 
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for overnight observation. Among patients that were admitted for treatment, 22% of them had ST 
confounders. This means that about 1 in 5 patients that were admitted to hospital, ST-segment 
monitoring was of limited value. The presence of ST confounders was associated with a median 
of 1 day longer length of stay (Figure 7, p<0.001). 
 
Figure 6. Relationship between presence of ST Confounders and Admission Status 
 
Figure 7. Relationship between presence of ST Confounders and LOS 
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6.0  DISCUSSION 
6.1 OVERVIEW 
This study was conducted to define the frequency of chest-pain patients with ST confounders and 
evaluate the clinical significance of these ECG abnormalities. In this secondary analysis of an 
existing data set, 750 patients that presented to the emergency department with chest pain were 
studied; majority of the patients were male and 40% were identified racially as black. The most 
prevalent final diagnosis for chest pain was undifferentiated chest pain, followed by non-ischemic 
cardiopulmonary, ACS, and non-cardiac related. Nearly 75% of patients were either admitted for 
treatment or overnight observation, with vast majority having a final diagnosis of non-ischemic 
chest pain. In comparison to Weinstock’s study that found almost 50% of patients being admitted, 
this is a relatively large amount of admissions (Weinstock et al., 2015). About 1 in 6 patients 
overall had non-ischemic ST-segment changes. Older age, hypertension, coronary artery disease, 
angina, diabetes mellitus, hyperlipidemia, history of MI and CHF, past CABG and PCI were all 
related to the presence of ST confounders. Non-ischemic cardiopulmonary patients had the highest 
prevalence of ST confounders with about 1 in 5 having a confounder, but the ST confounders could 
be found among all etiological groups. 1 in 5 patients admitted for treatment had an ST confounder, 
which was significantly associated with increased length of stay. 
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6.2 SAMPLE CHARACTERISTICS AND MAGNITUDE OF PROBLEM 
Some striking CAD risk factor data were that normal weight and obesity were almost equally 
prevalent and that a clear majority of the patients had hypertension, exemplifying that obesity class 
and hypertension are key components in CAD risk factor assessment. Additionally, over half of 
the patients that were admitted overnight had undifferentiated chest pain diagnoses. Although these 
patients pose a threat to healthcare economics related to the use of time and resources spent on 
finding a diagnosis, it can be seen in a positive light that people take chest pain seriously and seek 
medical attention.  Results showed that about 16% of the sample size had an ST-segment 
monitoring confounder; this means that about 1 in 6 patients that come in to the ED with chest 
pain have an ECG abnormality that hinders cardiac telemetry monitoring from accurately detecting 
an acute myocardial ischemia. 
6.3 RELATIONSHIPS BETWEEN ST CONFOUNDERS AND CLINICAL 
VARIABLES 
Sex and race were not determinants of ST confounders presence, but age and CAD risk factors had 
significant relationships with the presence of confounders. Clinical presentation also did not have 
significant relationships to presence of ST confounders. The presence of confounders also had 
statistically significant relationships with chest pain etiologies; cardiac related etiology (ACS or 
non-ischemic cardiopulmonary) had the highest prevalence of ST confounders. Many etiologies 
in this category are chronic in nature, such as heart failure, as well as many ST confounders are 
also chronic as they are conduction related issues. Of the patients that were admitted for treatment, 
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1 in 5 had an ST confounder. If a nurse working on a telemetry monitored floor had a five-patient 
assignment, one of her patients may have an ST confounder that causes the ST-segment monitor 
to be constantly alarming, leading to alarm fatigue for the nurse. Clinicians may be misled by the 
alarms into thinking the patient is experiencing acute myocardial ischemia, which could result in 
unnecessary diagnostic testing, a longer hospital stay, and/or increased cost of care (Drew, Wung, 
Adams, & Pelter, 1998). Our data supports this notion and demonstrates that the presence of 
confounders is associated with a length of stay that is 1 day longer, which increases healthcare 
costs and potentially avoidable diagnostic testing. 
6.4 LIMITATIONS 
The parent study did not collect data on false alarms from monitors in telemetry units, which could 
have provided more in depth analysis of the relationship between the presence of confounders and 
the frequency of false alarms leading to alarm fatigue. Another future area for improvement is 
examining the relationship between the presence of ST confounders and important clinical 
outcomes, for instance rate of 30 day readmissions, re-infarctions, or mortality. These outcome 
data are being collected in the ongoing EMPIRE study, but they were not available for this 
secondary analysis. 
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6.5 CONCLUSION 
This study opens the door to future research by quantifying the magnitude of the problem nurses 
face with patients that present with chest pain and have ST confounders. Although computerized 
telemetry cardiac monitoring is clinically valuable for observation in patients that present with 
chest pain, nurses need to understand their limitations for observing high-risk patients with non-
ischemic ECG confounders. Future research should explore alternative methods of monitoring 
patients with ST confounders. Perhaps, more frequent vital signs should be taken on these patients 
or more frequent observation of serum electrolyte levels and cardiac biomarkers. Future research 
can examine the frequency of unnecessary treatment in ST-segment monitoring false alarms. 
Additionally, future research can investigate methods to enhance existing computerized algorithms 
specifically for patients that have ST-segment monitoring confounders. 
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